| 11331306 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases |
John E. Donello, Daniel W. Gil |
2022-05-17 |
| 11285134 |
Presbyopia treatments |
Michael R. Robinson, Jaya Giyanani, Anuradha V. Gore, Sungwook Lee, Haixia Liu +2 more |
2022-03-29 |
| 11077053 |
Alpha-2-adrenergic receptor agonists for treatment of presbyopia, visual glare, visual starbursts, visual halos and night myopia |
Daniel W. Gil, Wayne Chen, Miguel Alcantara |
2021-08-03 |
| 10610518 |
Presbyopia treatments |
Michael R. Robinson, Jaya Giyanani, Anuradha V. Gore, Sungwook Lee, Haixia Liu +2 more |
2020-04-07 |
| 10555933 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases |
John E. Donello, Daniel W. Gil |
2020-02-11 |
| 10201535 |
Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
Edward C. Hsia, John E. Donello, Daniel W. Gil |
2019-02-12 |
| 9889088 |
Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect |
Daniel W. Gil, John E. Donello |
2018-02-13 |
| 9308201 |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
Edward C. Hsia, John E. Donello, Daniel W. Gil |
2016-04-12 |
| 9283217 |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
Edward C. Hsia, John E. Donello, Daniel W. Gil |
2016-03-15 |
| 9199989 |
N—(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
Liming Wang, Michael E. Garst, Ken Chow, Santosh C. Sinha |
2015-12-01 |
| 9095576 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases |
John E. Donello, Daniel W. Gil |
2015-08-04 |
| 9034896 |
N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst |
2015-05-19 |
| 8853251 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases |
Daniel W. Gil, Ken Chow, Liming Wang, Michael E. Garst, John E. Donello |
2014-10-07 |
| 8815861 |
N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst |
2014-08-26 |
| 8741921 |
N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst |
2014-06-03 |
| 8513419 |
N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
Santosh C. Sinha, Liming Wang, Ken Chow, Michael E. Garst |
2013-08-20 |